On Tuesday, Canadian cannabis company Tilray, Inc. (NASDAQ: TLRY) (TSX: TLRY) announced the launch of a new brand dubbed Symbios.
This is the inaugural brand produced by the "new" Tilray and will provide medical patients with a broader spectrum of formats and cannabinoid ratios at a fair and reasonable price.
The offering includes a myriad of cannabis products such as dry flower, oils and pre-rolls.
The Canadian cannabis giant recently wrapped up a merger with cannabis grower Aphria (NASDAQ: APHA) after months of negotiations.
Cantor Fitzgerald's Pablo Zuanic recently lowered a …